Newsroom

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Space Economy UCITS ETF 14.09.2026 FSPC.LN IE000ANMCD25 50,002.00 USD 999,966.46 19.999  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest US Equity Max Buffer UCITS ETF - March 14.09.2026 MMAR.LN IE0002PPCMH6 50,002.00 USD 1,344,938.71 26.898  ...

TOKIO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (Hauptsitz: Chuo-ku, Tokio; Präsident und CEO: Toshiaki Nagasato) wird vom 6. bis 8. Oktober 2026 auf der CPHI Mailand 2026 in der Fiera Milano in Mailand, Italien, erstmals als Pharmasegment der Meiji Group vertreten sein. Auf der Messe wird das Pharmasegment der Meiji Group seine 80-jährige Expertise in den Bereichen Qualitätskontrolle nach japanischen Standards, Produktion und Liefernetzwerk von Japan nach Europa, Indien und Südostasien pr...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Nuclear Power UCITS ETF 14.09.2026 RCTR.LN IE000J5PESP7 2,650,002.00 USD 47,197,052.23 17.810  ...

LONDON--(BUSINESS WIRE)--    DMO-TAS041/3729/002         The Minster Building21 Mincing LaneLondonEC3R 7AG T 020 7862 6500F 020 7862 6509www.dmo.gov.uk           A123\26 15 September 2026   PRESS NOTICE   RESULT OF THE SALE BY TENDER OF UP TO £750 MILLION OF 4¼% TREASURY GILT 2040The United Kingdom Debt Management Office ("DMO") announces that the tender of up to £750 million of 4¼% Treasury Gilt 2040 (ISIN Code: GB00B6460505) has been allocated as follows:(Note: all prices in this notice are q...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Europe Rising Dividend Achievers UCITS ETF 14.09.2026 EDVY.LN IE000CPG9HG3 50,002.00 EUR 1,132,761.11 22.654  ...

TOKYO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (siège social : Chuo-ku, Tokyo ; président-directeur général : Toshiaki Nagasato) fera ses débuts en tant que division pharmaceutique du groupe Meiji au salon CPHI Milan 2026, qui se tiendra à la Fiera Milano, à Milan, en Italie, du 6 au 8 octobre 2026. Lors de ce salon, la division pharmaceutique de Meiji Group mettra en avant ses 80 ans d’expertise en matière de contrôle qualité selon les normes japonaises, de fabrication et de réseau d’app...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest US Equity Max Buffer UCITS ETF - December 14.09.2026 MDEC.LN IE0007FIJUO5 50,002.00 USD 1,425,599.34 28.511  ...

BILLERICA, Mass.--(BUSINESS WIRE)--Access Vascular, Inc. (AVI), a medical device company specializing in developing advanced vascular access solutions, today announced its HydroMID® midline catheter has received an Innovative Technology contract from Vizient®, the nation’s largest provider-driven healthcare performance improvement company. The contract was awarded based on review of the HydroMID® device from hospital experts who serve on one of Vizient’s client-led councils, and it signifies to...